Newsroom | 5673 results

Sorted by: Latest

Alternative Medicine
-

Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Needham Virtual Healthcare Conference on April 14, 2026 and will participate in a fireside chat at 12:45 pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will...
-

WM Technology, Inc. Announces Voluntary Delisting From Nasdaq

IRVINE, Calif.--(BUSINESS WIRE)--WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Global Select Market (“Nasdaq”). The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) to delist its Class A common stock and warrants from Nasdaq and to deregister its...
-

New Wondr Health/Harris Poll: Two in Three Workers Say Employer Health Benefits Would Influence GLP-1 Use

DALLAS--(BUSINESS WIRE)--As demand for GLP-1 medications continues to surge across the U.S., accelerated by expanding clinical indications, more market entrants, and novel pricing and access models, new research suggests employer-sponsored health benefits may play a significant role in determining who ultimately uses these treatments. A national survey conducted by The Harris Poll on behalf of Wondr Health, the leading provider of behavioral weight management and GLP-1 clinical solutions, finds...
-

Canopy Growth Unveils New Brand ‘Deelish’: High THC, Everyday Price

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the everyday consumer with an everyday price. Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. And unlike brands built around a single profile, Deelish rotates its genetic lineup regularly, giving consumers access to a curated range of...
-

Bloom Expands Partnership with Cresco Labs to Enter Pennsylvania’s Vape-Forward Medical Market

PHILADELPHIA--(BUSINESS WIRE)--Bloom, a nationally recognized leader known for its proprietary hardware platform and refined strain formulations, is entering one of the country’s largest medical-only cannabis markets with its launch in Pennsylvania in partnership with Cresco Labs (CSE: CL) (OTCQX: CRLBF), one of the largest multi-state cannabis operators in the U.S. This marks Bloom’s second market launch with Cresco Labs, following a successful debut at Sunnyside dispensaries across Florida in...
-

Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the “Transaction”) of Sanity Group GmbH (“Sanity Group”) and the related private placement financing (the “Private Placement”) with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco (“...
-

Canopy Growth’s Apollo Cannabis Clinics Named Best Medical Cannabis Clinic

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that its Apollo Cannabis Clinics (“Apollo”) has been named Best Medical Cannabis Clinic in the 2025 Toronto Star’s Readers’ Choice Awards, a public vote that reflects the trust patients place in Apollo’s care. Apollo represents the Company’s commitment to raising the standard of medical cannabis and making quality treatment accessible to every Canadian. “...
-

VIVAZEN® Urges Immediate Action on 7-OH as U.S. House of Representatives Examines End Needless Distribution of 7-OH Act

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomed congressional scrutiny of 7-hydroxymitragynine (7-OH) as the House Energy and Commerce Subcommittee on Health holds a legislative hearing on H.R. 8000, the End Needless Distribution of 7-OH Act, introduced by Representative Gus Bilirakis (R-FL) and related illicit-drug legislation. The hearing underscores growing concern in Washington about 7-OH, as members of the subcommittee called on the Drug Enforc...
-

Cornbread Hemp Enters the Medicare Hemp Pilot as Exclusive Supplier to GPO Serving 68,000 Provider Locations

LOUISVILLE, Ky.--(BUSINESS WIRE)--Cornbread Hemp, a national leader in USDA organic CBD products, today announced that it has secured an exclusive contract with Alliant Purchasing, a national Group Purchasing Organization (GPO) whose member network includes Accountable Care Organizations (ACOs) designated to participate in the landmark Substance Access Beneficiary Engagement Incentive (BEI) administered by the Center for Medicare and Medicaid Innovation (CMMI). The contract names Cornbread Hemp...
-

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported the fourth quarter and full-year 2025 financial results and business highlights. “COMP360 is shaping the future of mental healthcare, and we are moving the field of psychiatric medicine forward for the millions of people urgently needing better options. As the potential first classic psychedelic ap...